Digestive Diseases and Sciences

, Volume 50, Issue 9, pp 1734–1740

The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis

  • Cynthia Levy
  • James Lymp
  • Paul Angulo
  • Gregory J. Gores
  • Nicholas Larusso
  • Keith D. Lindor
Article

DOI: 10.1007/s10620-005-2927-8

Cite this article as:
Levy, C., Lymp, J., Angulo, P. et al. Dig Dis Sci (2005) 50: 1734. doi:10.1007/s10620-005-2927-8

Abstract

CA 19-9 has been used with questionable accuracy to aid diagnosis of cholangiocarcinoma complicating primary sclerosing cholangitis. We aimed to characterize the test properties of CA 19-9 and of a change in CA 19-9 over time in predicting cholangiocarcinoma. Charts of 208 patients were reviewed. Fourteen patients had cholangiocarcinoma. Median CA 19-9 was higher with cholangiocarcinoma (15 vs. 290 U/ml, p < 0.0001). A cutoff of 129 U/ml provided: sensitivity 78.6%, specificity 98.5%, adjusted positive predictive value 56.6% and negative predictive value 99.4%. The median change over time was 664 U/ml in cholangiocarcinoma compared to 6.7 U/ml in primary sclerosing cholangitis alone (p < 0.0001). A cutoff of 63.2 U/ml for change in CA 19-9 provided: sensitivity 90%, specificity 98% and positive predictive value 42%. Only 2 patients with cholangiocarcinoma were the candidates for curative therapy. In conclusion, the positive predictive value of an elevated CA 19-9 was 56.6%; only advanced cases were detected by this method.

Keywords

primary sclerosing cholangitis cholangiocarcinoma biliary tract malignancy carbohydrate 19-9 

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Cynthia Levy
    • 1
  • James Lymp
    • 2
  • Paul Angulo
    • 3
  • Gregory J. Gores
    • 1
  • Nicholas Larusso
    • 3
  • Keith D. Lindor
    • 1
    • 4
  1. 1.Division of Gastroenterology, Hepatology and NutritionUniversity of FloridaGainesville
  2. 2.Biostatistics at Mayo Clinic RochesterMinnesota
  3. 3.Gastroenterology and Hepatology at Mayo ClinicRochester
  4. 4.Division of Gastroenterology and HepatologyMayo Clinic RochesterRochester

Personalised recommendations